Postsynaptic membrane fusion and long-term potentiation

Science

Volumn 279, Issue 5349, 1998, Pages 399-403

  Lledo, Pierre Marie ^a,d   Zhang, Xiangyang ^b   Südhof, Thomas C ^b   Malenka, Robert C ^c   Nicoll, Roger A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POSTSYNAPTIC RECEPTOR;

ARTICLE; LONG TERM POTENTIATION; MEMBRANE FUSION; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; REGULATORY MECHANISM; SYNAPTIC TRANSMISSION;

AMINO ACID SEQUENCE; ANIMALS; BOTULINUM TOXINS; CARRIER PROTEINS; ETHYLMALEIMIDE; EXCITATORY POSTSYNAPTIC POTENTIALS; EXOCYTOSIS; GUINEA PIGS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MEMBRANE FUSION; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; N-ETHYLMALEIMIDE-SENSITIVE PROTEINS; PATCH-CLAMP TECHNIQUES; PEPTIDES; PYRAMIDAL CELLS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; SOLUBLE N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEINS; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION; VESICULAR TRANSPORT PROTEINS;

EID: 0032536033     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.279.5349.399     Document Type: Article

References (44)

1. T. V. P. Bliss and G. L. Collingridge, Nature 361, 31 (1993); A. U. Larkmann and J. J. B. Jack, Curr. Opin. Neurobiol. 5, 324 (1995); R. A. Nicoll and R. C. Malenka, Nature 377, 115 (1995).
2. T. V. P. Bliss and G. L. Collingridge, Nature 361, 31 (1993); A. U. Larkmann and J. J. B. Jack, Curr. Opin. Neurobiol. 5, 324 (1995); R. A. Nicoll and R. C. Malenka, Nature 377, 115 (1995).
3. T. V. P. Bliss and G. L. Collingridge, Nature 361, 31 (1993); A. U. Larkmann and J. J. B. Jack, Curr. Opin. Neurobiol. 5, 324 (1995); R. A. Nicoll and R. C. Malenka, Nature 377, 115 (1995).
4. T. M. Jessell and E. R. Kandel, Cell 72, 1 (1993).
5. J. T. R. Isaac, R. A. Nicoll, R. C. Malenka, Neuron 15, 427 (1995); D. Liao, N. A. Hessler, R. Malinow, Nature 375, 400 (1995); G. M. Durand, Y. Kovalchuk, A. Konnerth, ibid. 381, 71 (1996).
6. J. T. R. Isaac, R. A. Nicoll, R. C. Malenka, Neuron 15, 427 (1995); D. Liao, N. A. Hessler, R. Malinow, Nature 375, 400 (1995); G. M. Durand, Y. Kovalchuk, A. Konnerth, ibid. 381, 71 (1996).
7. J. T. R. Isaac, R. A. Nicoll, R. C. Malenka, Neuron 15, 427 (1995); D. Liao, N. A. Hessler, R. Malinow, Nature 375, 400 (1995); G. M. Durand, Y. Kovalchuk, A. Konnerth, ibid. 381, 71 (1996).
8. 2. All recordings were made in the CA1 region after removal of the CA3 region. Monosynaptic excitatory postsynaptic potentials (EPSPs) were evoked by stimulating close to the CA1 pyramidal cell layer, and neurons were recorded in bridge mode with sharp microelectrodes containing 2 M potassium acetate (pH 7.3; impedance of 50 to 80 megohms).
9. 2. All recordings were made in the CA1 region after removal of the CA3 region. Monosynaptic excitatory postsynaptic potentials (EPSPs) were evoked by stimulating close to the CA1 pyramidal cell layer, and neurons were recorded in bridge mode with sharp microelectrodes containing 2 M potassium acetate (pH 7.3; impedance of 50 to 80 megohms).
10. 4, and 250 mM imidazole at pH 7.5. This medium was dissolved 1/26 with the patch pipette solution to give a final concentration for SNAP of 80 μg/ml, then briefly sonicated and placed in the tips of the whole-cell pipettes. The pipettes were then backfilled with the standard whole-cell pipette solution. Baseline values of EPSCs were obtained from averages of responses during the first 2 min (time 0 on the graph) and defined as 100% for subsequent analyses.
11. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); N. Calakos and R. H. Scheller, Physiol. Rev. 76, 1 (1996); Y. Goda, Proc. Natl. Acad. Sci. U.S.A. 94, 769 (1997).
12. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); N. Calakos and R. H. Scheller, Physiol. Rev. 76, 1 (1996); Y. Goda, Proc. Natl. Acad. Sci. U.S.A. 94, 769 (1997).
13. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); N. Calakos and R. H. Scheller, Physiol. Rev. 76, 1 (1996); Y. Goda, Proc. Natl. Acad. Sci. U.S.A. 94, 769 (1997).
14. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); N. Calakos and R. H. Scheller, Physiol. Rev. 76, 1 (1996); Y. Goda, Proc. Natl. Acad. Sci. U.S.A. 94, 769 (1997).
15. W. M. DeBello et al., Nature 373, 626 (1995).
16. 2-terminal domain of α- and β-SNAP (designed to disrupt the protein-protein interaction of SNAPs) was QSFFSGLFGGSSKIEEACE (26). The peptide was amidified on the COOH-terminal and purified by reverse phase high-pressure liquid chromatography.
17. The scrambled S19 peptide, which was prepared in the same way as N19, was GFAESLFQSIEKESGFSCG (26).
18. W. B. Huttner, Nature 365, 104 (1993); G. Schiavo, O. Rossetto, F. Benfenati, B. Poulain, C. Montecucco, Ann. N.Y. Acad. Sci. 710, 65 (1994); T. C. Südhof, P. DeCamilli, H. Niemann, R. Jahn, Cell 75, 1 (1993); H. T. McMahon et al., Nature 364, 346 (1993).
19. W. B. Huttner, Nature 365, 104 (1993); G. Schiavo, O. Rossetto, F. Benfenati, B. Poulain, C. Montecucco, Ann. N.Y. Acad. Sci. 710, 65 (1994); T. C. Südhof, P. DeCamilli, H. Niemann, R. Jahn, Cell 75, 1 (1993); H. T. McMahon et al., Nature 364, 346 (1993).
20. W. B. Huttner, Nature 365, 104 (1993); G. Schiavo, O. Rossetto, F. Benfenati, B. Poulain, C. Montecucco, Ann. N.Y. Acad. Sci. 710, 65 (1994); T. C. Südhof, P. DeCamilli, H. Niemann, R. Jahn, Cell 75, 1 (1993); H. T. McMahon et al., Nature 364, 346 (1993).
21. W. B. Huttner, Nature 365, 104 (1993); G. Schiavo, O. Rossetto, F. Benfenati, B. Poulain, C. Montecucco, Ann. N.Y. Acad. Sci. 710, 65 (1994); T. C. Südhof, P. DeCamilli, H. Niemann, R. Jahn, Cell 75, 1 (1993); H. T. McMahon et al., Nature 364, 346 (1993).
22. The botulinum toxin was heated to 90°C for 30 min, and its solubility after denaturation was checked by spectrophotometry.
23. J. Spacek and K. Harris, J. Neurosci. 17, 190 (1997).
24. L. E. Westrum and T. Blackstad, J. Comp. Neurol. 119, 281 (1962); S. B. Tarrant and A. Routtenberg, Tissue Cell 9, 461 (1977); J. R. McWilliams and G. Lynch, Brain Res. 211, 158 (1981).
25. L. E. Westrum and T. Blackstad, J. Comp. Neurol. 119, 281 (1962); S. B. Tarrant and A. Routtenberg, Tissue Cell 9, 461 (1977); J. R. McWilliams and G. Lynch, Brain Res. 211, 158 (1981).
26. L. E. Westrum and T. Blackstad, J. Comp. Neurol. 119, 281 (1962); S. B. Tarrant and A. Routtenberg, Tissue Cell 9, 461 (1977); J. R. McWilliams and G. Lynch, Brain Res. 211, 158 (1981).
27. O. Mundigl et al., J. Cell Biol. 122, 1207 (1993).
28. E. Ziff et al., personal communication.
29. J. M. Henley et al., personal communication.
30. M. M. Maletic-Savatic, T. Koothan, R. Malinow, Soc. Neurosci. Abstr. 21, 1743 (1995).
31. Y. Dan and M.-M. Poo, Curr. Opin. Neurobiol. 4, 95 (1994).
32. R. Girod et al., J. Neurosci. 15, 2826 (1995); J. R. Coorssen, H. Schmitt, W. Almers, EMBO J. 15, 3787 (1996); A. Rodriguez, P. Webster, J. Ortego, N. W. Andrews, J. Cell Biol. 137, 93 (1997).
33. R. Girod et al., J. Neurosci. 15, 2826 (1995); J. R. Coorssen, H. Schmitt, W. Almers, EMBO J. 15, 3787 (1996); A. Rodriguez, P. Webster, J. Ortego, N. W. Andrews, J. Cell Biol. 137, 93 (1997).
34. R. Girod et al., J. Neurosci. 15, 2826 (1995); J. R. Coorssen, H. Schmitt, W. Almers, EMBO J. 15, 3787 (1996); A. Rodriguez, P. Webster, J. Ortego, N. W. Andrews, J. Cell Biol. 137, 93 (1997).
35. S. Cash, Y. Dan, M.-M. Poo, R. Zucker, Neuron 16, 745 (1996); M. Glitsch, I. Llano, A. Marty, J. Physiol. 497, 531 (1996).
36. S. Cash, Y. Dan, M.-M. Poo, R. Zucker, Neuron 16, 745 (1996); M. Glitsch, I. Llano, A. Marty, J. Physiol. 497, 531 (1996).
37. It should be noted that while some reduction in the potentiation was evident shortly after the tetanus in the presence of inhibitors of membrane fusion, this potentiation decayed over a 10-to 30-min period. There are a number of possible explanations for this remaining short-term potentiation (STP), which is of longer duration than posttetanic potentiation. One possibility, which we do not favor, is that this STP is mechanistically distinct from LTP. Alternatively, the blockade of membrane fusion may not be complete, and multiple fusion events may be required to stabilize the potentiation.
38. N. Eshhar, R. S. Petralia, C. A. Winters, A. S. Niedzielski, R. J. Wenthold, Neuroscience 57, 943 (1993).
39. K. V. Kandror and P. K. Pilch, Am. J. Physiol. 271, E1 (1996).
40. I. Jo, H. W. Harris, A. M. Amendt-Raduege, R. R. Majewski, T. G. Hammond, Proc. Natl. Acad. Sci. U.S.A. 92, 1876 (1995); N. Franki, F. Macaluso, W. Schubert, L. Gunther, R. M. Hays, Am. J. Physiol. 269, C797 (1995).
41. I. Jo, H. W. Harris, A. M. Amendt-Raduege, R. R. Majewski, T. G. Hammond, Proc. Natl. Acad. Sci. U.S.A. 92, 1876 (1995); N. Franki, F. Macaluso, W. Schubert, L. Gunther, R. M. Hays, Am. J. Physiol. 269, C797 (1995).
42. Q. Wan et al., Nature 388, 686 (1997).
43. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
44. We thank H. Czerwonka for secretarial assistance. P.-M.L. was supported by CNRS and by a North Atlantic Treaty Organization fellowship. R.A.N. is a member of the Keck Center for Integrative Neurobiology and the Silvio Conte Center for Neuroscience Research. R.C.M. is a member of the Center for Neurobiology and Psychiatry and the Center for the Neurobiology of Addiction. R.A.N. is supported by grants from the NIH. R.C.M. is supported by grants from the NIH, the Human Frontier Science Program, and the McKnight Endowment Fund for Neuroscience.